Increased plasma HDL-cholesterol and apo A-I in breast cancer patients undergoing adjuvant tamoxifen therapy.
Mastroianni
A
A
Unita' Operativa Medicina di Laboratorio 1 Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.
Bellati
C
C
Facchetti
G
G
Oldani
S
S
Franzini
C
C
Berrino
F
F
D000328:Adult; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D016632:Apolipoprotein A-I / Q000097:blood* / Q000187:drug effects; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D008076:Cholesterol, HDL / Q000097:blood* / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D006801:Humans; D008875:Middle Aged; D013629:Tamoxifen / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D018931:Antineoplastic Agents, Hormonal; D016632:Apolipoprotein A-I; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014280:Triglycerides; D013629:Tamoxifen